SKI Market

Indian Indices

Sensex

84,273.92 208.17
( 0.25%)

Global Indices

Nasdaq

50,215.24 58.36
(0.12%)

Dow Jones

6,964.30 -21.52
(-0.31%)

Hang Seng

57,678.97 1,315.03
(2.33%)

Nikkei 225

10,354.92 -31.31
(-0.30%)

Forex

USD-INR

90.44 0.11
(0.13%)

EUR-INR

106.84 0.33
(0.31%)

GBP-INR

123.03 0.35
(0.29%)

JPY-INR

0.58 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

38.33

36146.38

EPS(TTM)

Face Value()

Div & Yield %

75.48

0.97

Back

Enbee Trade & Finance standalone net profit rises 160.00% in the June 2025 quarter

Aug 02,2025

Net profit of Enbee Trade & Finance rose 160.00% to Rs 2.47 crore in the quarter ended June 2025 as against Rs 0.95 crore during the previous quarter ended June 2024. Sales rose 95.44% to Rs 7.29 crore in the quarter ended June 2025 as against Rs 3.73 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	7.29	3.73	95
OPM %	65.16	57.64	-
PBDT	3.57	1.35	164
PBT	3.41	1.21	182
NP	2.47	0.95	160

84,273.92 208.17 ( 0.25%)

50,215.24 58.36 (0.12%)

6,964.30 -21.52 (-0.31%)

57,678.97 1,315.03 (2.33%)

10,354.92 -31.31 (-0.30%)

90.44 0.11 (0.13%)

106.84 0.33 (0.31%)

123.03 0.35 (0.29%)

0.58 0.00 (-0.07%)